D5 Logo (Tradjenta 5 mg)
Generic Name: linagliptin
Pill with imprint D5 Logo is Red, Round and has been identified as Tradjenta 5 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc..
Tradjenta is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Tradjenta 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D5 Logo
Tradjenta
- Generic Name:
- linagliptin
- Imprint:
- D5 Logo
- Strength:
- 5 mg
- Color:
- Red
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00597-0140
More about Tradjenta (linagliptin)
- Tradjenta Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
